Clinical Trial Update: A Study of MGC026 in Participants With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for MGC026 in participants with advanced solid tumors; study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Cervical Cancer
• Colorectal Cancer
• Endometrial Cancer
• Melanoma
• Non-small Cell Lung Cancer
• Sarcoma
• Small Cell Lung Cancer

Drugs mentioned

• MGC026

Snippet

Sponsor: MacroGenics | Conditions: Advanced Solid Tumor, Advanced Cancer | Phase 1 | Status: RECRUITING